Clinical trial
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have…
NCT00112749 · Jonsson Comprehensive Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00112749 |
|---|---|
| Title | Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer |
| Official title | Does Blocking Proinflammatory Cytokines Diminish Cancer-Related Fatigue? |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | American Cancer Society, Inc. |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Fatigue |
| Intervention type | Biological, Other |
| Interventions | infliximab, Clinical Assessment, Self-report questionnaires, Immune Assessment |
| Enrollment | 7 |
| Start date | Feb 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Nov 1, 2012 |
| First posted | Jun 3, 2005 |
| Last update posted | Jul 31, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: